Why does activated partial thromboplastin time prolongation occur in severe fever with thrombocytopenia syndrome?

被引:5
|
作者
Mizoe, Atsushi [1 ]
Sakaue, Junya [2 ]
Takahara, Noriko [1 ]
机构
[1] Ako City Hosp, Dept Internal Med, Ako, Hyogo, Japan
[2] Kyoto Univ Hosp, Integrated Clin Educ Ctr, Kyoto, Japan
关键词
infectious diseases; haematology (incl blood transfusion); VIRUS; TICK;
D O I
10.1136/bcr-2020-235447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe fever with thrombocytopenia syndrome (SFTS) is caused by infection with SFTS virus and this mortality rate is 16.2% to 30%. An 85-year-old male patient presented to the emergency department of the hospital with primary complaints of fever and consciousness disturbance. Haemophagocytic syndrome and prolonged activated partial thromboplastin time (APTT) without associated prolonged prothrombin time were observed, suggesting SFTS, which was eventually diagnosed. APTT-only prolongation has been reported previously with SFTS, but the mechanism is unknown. The absence of coagulation factors was determined by a cross-mixing study. In addition, examination of intrinsic coagulation factors showed reduced factor XI activity. These results suggest that factor XI is causally related to APTT-only prolongation in SFTS.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] An international study on activated partial thromboplastin time prolongation. Part 2: Interpretative commenting
    Miquel Bauca, Josep
    Ajzner, Eva
    Cadamuro, Janne
    Hillarp, Andreas
    Kristoffersen, Ann Helen
    Meijer, Piet
    CLINICA CHIMICA ACTA, 2022, 535 : 174 - 179
  • [32] ERRONEOUS ACTIVATED PARTIAL THROMBOPLASTIN TIME
    OWEN, J
    PAYNE, E
    CARSTAIRS, K
    ANNALS OF INTERNAL MEDICINE, 1978, 89 (01) : 146 - 146
  • [33] FALSE PROLONGATION OF PARTIAL THROMBOPLASTIN TIME ACTIVATED (TTPA) IN PATIENTS WITH HIGH CONCENTRATIONS OF CONVENTIONAL PCR
    Campos Alvarez, R. M.
    Palacio Heidy, Campo J.
    Garzon Lopez, S.
    Mancheno Trujillo, T.
    Cabeza De Vaca, Verdugo M. V.
    HAEMATOLOGICA, 2015, 100 : 126 - 126
  • [34] Activated partial thromboplastin time evaluation
    Spinler, SA
    PHARMACOTHERAPY, 2001, 21 (03): : 363 - 364
  • [35] PROLONGATION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS TREATED WITH THERAPEUTIC HYPOTHERMIA AND INTRAVENOUS HEPARIN.
    Wahby, Krista
    Soubani, Ayman
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A128 - A128
  • [36] An international study on activated partial thromboplastin time prolongation. Part 1: Analytical results
    Miquel Bauca, Josep
    Ajzner, Eva
    Cadamuro, Janne
    Hillarp, Andreas
    Kristoffersen, Ann Helen
    Meijer, Piet
    CLINICA CHIMICA ACTA, 2022, 535 : 167 - 173
  • [37] Artifactual prolongation of activated partial thromboplastin time with PEGylated compounds in silica-based assays
    Murphy, Bethanne
    Parrula, Maria C. M.
    Perigard, Christopher J.
    Li, Jinze
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (08) : 876 - 882
  • [38] Prolonged activated partial thromboplastin time in patients with antiphospholipid antibody syndrome
    Dyer, James R.
    Raj, Tilak
    ANESTHESIA AND ANALGESIA, 2006, 103 (06): : 1586 - 1587
  • [39] Correlation of whole blood activated partial thromboplastin time and plasma activated partial thromboplastin time in haemodialysis patients
    Low, CL
    Eisele, G
    Bailie, GR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (12) : 2523 - 2523
  • [40] The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency
    Abildgaard, Anders
    Hvas, Anne-Mette
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (07) : E297 - E300